A
Price
$126.70
Change
+$0.21 (+0.17%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
35.72B
56 days until earnings call
Intraday BUY SELL Signals
WRBY
Price
$25.80
Change
-$1.19 (-4.41%)
Updated
Jun 23, 04:20 PM (EDT)
Capitalization
3.31B
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

A vs WRBY

A vs WRBY Comparison Chart in %
View a ticker or compare two or three
VS
A vs. WRBY commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and WRBY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (A: $126.49 vs. WRBY: $26.99)
Brand notoriety: A and WRBY are both not notable
A represents the Medical Specialties, while WRBY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: A: 91% vs. WRBY: 98%
Market capitalization -- A: $35.72B vs. WRBY: $3.31B
A [@Medical Specialties] is valued at $35.72B. WRBY’s [@Pharmaceuticals: Other] market capitalization is $3.31B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $142.71B to $0. The average market capitalization across the [@Medical Specialties] industry is $15.2B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 1 FA rating(s) are green whileWRBY’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 1 green, 4 red.
  • WRBY’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than WRBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while WRBY’s TA Score has 6 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 5 bearish.
  • WRBY’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, WRBY is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а -3.14% price change this week, while WRBY (@Pharmaceuticals: Other) price change was +2.31% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.45%. For the same industry, the average monthly price growth was +2.48%, and the average quarterly price growth was -3.19%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.31%. For the same industry, the average monthly price growth was -0.98%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

A is expected to report earnings on Aug 18, 2026.

WRBY is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Medical Specialties (+0.45% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-2.31% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($35.7B) has a higher market cap than WRBY($3.31B). WRBY has higher P/E ratio than A: WRBY (2699.00) vs A (25.40). WRBY YTD gains are higher at: 23.864 vs. A (-6.662). A has higher annual earnings (EBITDA): 1.96B vs. WRBY (45.7M). A has more cash in the bank: 1.81B vs. WRBY (288M). WRBY has less debt than A: WRBY (238M) vs A (3.36B). A has higher revenues than WRBY: A (7.23B) vs WRBY (891M).
AWRBYA / WRBY
Capitalization35.7B3.31B1,078%
EBITDA1.96B45.7M4,293%
Gain YTD-6.66223.864-28%
P/E Ratio25.402699.001%
Revenue7.23B891M812%
Total Cash1.81B288M627%
Total Debt3.36B238M1,410%
FUNDAMENTALS RATINGS
A: Fundamental Ratings
A
OUTLOOK RATING
1..100
91
VALUATION
overvalued / fair valued / undervalued
1..100
6
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
44
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
62
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AWRBY
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
59%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 9 days ago
60%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 7 days ago
62%
Bearish Trend 8 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
52%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
A
Daily Signal:
Gain/Loss:
WRBY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MIDU72.070.83
+1.17%
Direxion Daily Mid Cap Bull 3X ETF
BRIF36.670.21
+0.59%
FIS Bright Portfolios Focused Equity ETF
SDHY16.150.03
+0.19%
PGIM Short Duration High Yield Opportunities Fund
BOTZ38.33-0.04
-0.10%
Global X Robotics & Artfcl Intllgnc ETF
JLQD41.25-0.06
-0.16%
Janus Henderson Corporate Bond ETF

WRBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, WRBY has been loosely correlated with TWST. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if WRBY jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WRBY
1D Price
Change %
WRBY100%
+3.97%
TWST - WRBY
45%
Loosely correlated
-2.91%
GKOS - WRBY
43%
Loosely correlated
+0.39%
MTD - WRBY
41%
Loosely correlated
+1.68%
GMED - WRBY
40%
Loosely correlated
-0.05%
A - WRBY
40%
Loosely correlated
-0.45%
More